USPTO serial 79293599
Serial No. 79293599
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 22, 2022
- Examiner
- PEREZ, STEVEN M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79293599?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacey J. Watson, Esq.
Stacey J. Watson, Esq. Markery Law LLCP.O. Box 84150Gaithersburg, MD 20883-4150UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for medical purposes; cells for medical use; biological cell preparations for the treatment of diseases and disorders, namely, ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke; pharmaceutical preparations for the prevention or treatment of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, urological, and peripheral artery related diseases and disorders, as well as type 1 and type 2 diabetes, gynecological disease and stroke | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, instruments and syringes for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, instruments and syringes for medical use for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; prosthetic tissues for parietal, visceral and vascular use; Medical apparatus and instruments, namely, syringes for medical purposes for injections for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; Medical apparatus and instruments, namely, syringes for medical purposes for injections for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments; eye testing machines and apparatus; Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for administration or transplanting of stem cells or cells differentiated from iPS cells, excluding any electrical pulsing technology instruments; and Medical apparatus and instruments, namely, instruments and syringes for treating of ophthalmic, central nervous system, respiratory, cardiovascular, liver, kidney, pancreatic, oncological, and gynecological diseases and disorders, as well as type 1 and type 2 diabetes and stroke, and for the regeneration of stem cells for medical purposes, excluding any electrical pulsing technology instruments | ACTIVE | — |
| 042 | Scientific and medical research and development in the field of cells; research and development of pharmaceuticals and medical apparatus and instruments for others; research and development services relating to medicines; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 16, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 22, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 22, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 6, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 6, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 6, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 27, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 29, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 12, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 12, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 23, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 22, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |